
Accelerators & VCs
De-risk U.S. market entry.
Strengthen portfolio commercialization.
Increase the probability of breakout outcomes.
HOW WE HELP
U.S. Market Entry & GTM Strategy
Reimbursement & Revenue Pathway Design
Portfolio Assessment & Prioritization
Founder Education & Cohort Programming
Embedded Expert Support (EIR Model)
Commercialization Execution & Refinement
We partner with organizations supporting HealthTech innovation and scaling companies into complex healthcare markets.
We plug in at the cohort, company, and portfolio level—helping you deliver differentiated value to founders while improving investment outcomes.
BUILD STRATEGY / CURRICULUM ON:
Medicaid
Medicare / Medicare Advantage
Commercial Payers
Self-Funded Employers
Accountable Care Organizations
Health Systems / Providers
TPAs
MGUs
PACE
What We Do
GTM Strategy & Market Positioning
We help companies translate their existing model into a strategy that reflects the realities of buyers, incentives, and fragmentation.​
​
-
Buyer landscape mapping (payers, providers, etc.)
-
ICP definition specific to U.S. healthcare buyers
-
State-by-state market entry strategy
-
Product adaptation for U.S. workflows and incentives
-
Market positioning and competitive benchmarking
Reimbursement & Revenue Pathway Design
Many companies fail not because of product quality. but because there is no viable path to revenue. We solve that early.​
​
-
Reimbursement landscape analysis (coverage, coding)
-
Identification of viable revenue pathways
-
Pricing strategy aligned to U.S. buyers
-
Timeline and expectations for “coverage to cash flow”
-
Risk assessment of reimbursement dependency
Portfolio Screening & Prioritization
Not every company is ready to go to market. We help you focus resources where success is most likely.
​
-
Commercial readiness assessment across portfolio
-
Identification of key GTM and reimbursement gaps
-
Prioritization of companies for U.S. expansion
-
Investment risk signaling tied to commercialization readiness
-
Strategic recommendations for portfolio allocation
Cohort Programming & Founder Education
We deliver structured programming that equips founders with the knowledge and frameworks needed to succeed.​
​
-
Workshops on GTM, reimbursement, and buyer strategy
-
Training on ICP definition and messaging
-
Education on payer vs. provider vs. employer dynamics
-
Office hours for participating companies
-
Optional deep-dive sessions for select teams
Embedded Expert / EIR Model
We integrate directly into your program or portfolio as commercialization experts.​
​
-
Structured involvement across cohorts or portfolio
-
Ongoing support in refining U.S. entry strategies
-
Pressure-testing GTM assumptions
-
Guidance on sequencing market entry decisions
-
Real-time feedback based on market realities
Commercialization Gap Analysis & Strategy
We identify and solve the most common failure points in market access before they become costly mistakes.​
​
-
Analysis of commercialization gaps across companies
-
Strategic roadmap to resolve key blockers
-
Alignment of product, buyer, and revenue strategy
-
Support in building credible growth narratives
-
Preparation for investor scrutiny (e.g., Series A readiness)

Ways to Work With Us
Let’s work together to equip your companies with the strategies they need to succeed and avoid the most common commercialization pitfalls.
Portfolio-Wide Assessment
A systematic approach to identifying which companies are best positioned for HealthTech success and where to focus resources.
GTM Strategy Building
We assess your portfolio or target cohort, identify commercialization gaps, and provide a clear strategy for enabling go-to-market success.
Cohort-Level Program
Structured workshops, office hours, and deep dives designed to equip founders with the tools and frameworks needed to navigate healthcare markets.
Embedded Partner
Ongoing, hands-on support across your cohort or portfolio to guide strategy, refine execution, and improve outcomes.

